WebTicagrelor or prasugrel vs. clopidogrel in combination with anticoagulation for treatment of acute coronary syndrome in patients with atrial fibrillation WebAug 28, 2024 · QUICK TAKE Dual Antiplatelet Therapy Post-PCI in Patients at High Bleeding Risk 02:07. Randomized trials have established the superiority of drug-eluting stents over bare-metal stents in patients ...

2024 ACC Expert Consensus Pathway for Anticoagulant …

WebAug 31, 2024 · Dual antiplatelet therapy (DAPT), often with a more potent thienopyridine than clopidogrel, is recommended for up to 1 year for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). To reduce bleeding after the early thrombotic period, various strategies have been tested. WebGuidelines for antithrombotic therapy are complex, especially if a patient has several indications that require antithrombotic therapy. In general, no patient should receive lifelong double or triple antithrombotic therapy. In this overview, we outline the most common indications for mono, double and triple antithrombotic therapy; the preferred … integris pharmacy oklahoma

Combining antiplatelet and anticoagulant therapy in …

WebJun 26, 2013 · Dual Antiplatelet Therapy in Acute Transient Ischemic Attack and Minor Stroke. Some patients with stroke and transient ischemic attack (TIA) of the brain are at … WebJun 25, 2024 · JAMA 2024 Jun 25. Two randomized studies challenge the need for prolonged DAPT. After percutaneous coronary intervention (PCI) with a drug-eluting stent (DES), current guidelines recommend dual antiplatelet therapy (DAPT) with aspirin and a thienopyridine lasting ≥6 months in patients with stable coronary artery disease … WebAug 28, 2024 · Sophia Antipolis, France – 28 Aug 2024: One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk patients preserves … integris philips